SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001214659-24-008009
Filing Date
2024-05-01
Accepted
2024-05-01 16:31:25
Documents
2

Document Format Files

Seq Description Document Type Size
1 p430241defa14a.htm DEFA14A 55624
2 GRAPHIC alzamendlogo_sm.jpg GRAPHIC 18173
  Complete submission text file 0001214659-24-008009.txt   81831
Mailing Address 3500 LENOX RD. NE SUITE 1500 ATLANTA GA 30326
Business Address 3500 LENOX RD. NE SUITE 1500 ATLANTA GA 30326 844-722-6333
Alzamend Neuro, Inc. (Filer) CIK: 0001677077 (see all company filings)

IRS No.: 811822909 | State of Incorp.: DE | Fiscal Year End: 0430
Type: DEFA14A | Act: 34 | File No.: 001-40483 | Film No.: 24903541
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)